1 |
Laudanski K, Wain J. Considerations for Cannabinoids in Perioperative Care by Anesthesiologists. J Clin Med 2022;11:558. [PMID: 35160010 DOI: 10.3390/jcm11030558] [Reference Citation Analysis]
|
2 |
Scipioni L, Ciaramellano F, Carnicelli V, Leuti A, Lizzi AR, De Dominicis N, Oddi S, Maccarrone M. Microglial Endocannabinoid Signalling in AD. Cells 2022;11:1237. [DOI: 10.3390/cells11071237] [Reference Citation Analysis]
|
3 |
Tiberi M, Evron T, Saracini S, Boffa L, Mercuri NB, Chintalacharuvu SR, Atamas SP, Chiurchiù V. Potent T cell-mediated anti-inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis. Neuropathol Appl Neurobiol 2021. [PMID: 34543449 DOI: 10.1111/nan.12768] [Reference Citation Analysis]
|
4 |
Abate G, Uberti D, Tambaro S. Potential and Limits of Cannabinoids in Alzheimer's Disease Therapy. Biology (Basel) 2021;10:542. [PMID: 34204237 DOI: 10.3390/biology10060542] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
5 |
Brunetti L, Leuci R, Carrieri A, Catto M, Occhineri S, Vinci G, Gambacorta L, Baltrukevich H, Chaves S, Laghezza A, Altomare CD, Tortorella P, Santos MA, Loiodice F, Piemontese L. Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114358] [Reference Citation Analysis]
|